Allan Perley Jarvis
Directeur/Membre du Conseil chez Prokarium Ltd.
Profil
Allan Perley Jarvis currently works at Prokarium Ltd., as Director and Prokarium Holdings Ltd., as Director from 2017.
Postes actifs de Allan Perley Jarvis
Sociétés | Poste | Début |
---|---|---|
Prokarium Ltd.
Prokarium Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Ltd. operates as a biopharmaceutical company that focuses on developing vaccination solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases. The company is headquartered in Keele, the United Kingdom. | Directeur/Membre du Conseil | - |
Prokarium Holdings Ltd.
Prokarium Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Holdings Ltd. provides management services. The private company is based in London, UK. The British company was founded in 2014. Kristen Albright has been the CEO of the company since 2018. | Directeur/Membre du Conseil | 13/10/2017 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Prokarium Ltd.
Prokarium Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Ltd. operates as a biopharmaceutical company that focuses on developing vaccination solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases. The company is headquartered in Keele, the United Kingdom. | Commercial Services |
Prokarium Holdings Ltd.
Prokarium Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Holdings Ltd. provides management services. The private company is based in London, UK. The British company was founded in 2014. Kristen Albright has been the CEO of the company since 2018. | Commercial Services |